The outlook of companies tied to Sildenafil's legacy presents a challenging investment scenario . While the initial boom generated substantial returns , generic copies have significantly eroded revenue. https://linkingbookmark.com/story21522255/the-copyright-and-the-pharmaceutical-sector-a-uncertain-investment